Projekte unter der Sponsorschaft der AIO-Studien-gGmbH

Thorakale Onkologie

AIO-TRK-0114: Maintaining ERBB blockade in EGFR-mutated lung cancer (MARBLE) - A randomized, open-label, phase II study of maintaining pan-ERBB blockade following platinum-based induction chemotherapy in patients with EGFR mutated, metastatic non-small-cell lung cancer progressing after first line treatment with afatinib (MARBLE)
 
AIO-TRK-0214: Induction therapy with gefitinib followed by taxane platinum chemotherapy and intercalated gefitinib in NSCLC stages II-IIIB with activating EGFR mutation – A single arm Phase II trial. (NeoIntercal)
 
AIO-TRK-0115: A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients with Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) (PRIMUS)
 
AIO-TRK-0215: Concordance study of OncoBEAM® EGFR mutation detection in circulating tumor DNA versus standard of care tissue-based EGFR testing for therapy selection and examination of emerging resistance in stage IV NSCLC patients
 
AIO-TRK-0315: Clinical Research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP)